Shanghai Rongtai Health Technology Corporation Limited (SHA:603579)
China · Delayed Price · Currency is CNY 22.45
+0.15 (0.67%)
May 6, 2026, 3:00 PM CST
SHA:603579 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,620 | 1,573 | 1,575 | 1,845 | 1,986 | 2,586 |
Other Revenue | - | - | 21.91 | 9.87 | 18.58 | 27.06 |
| 1,620 | 1,573 | 1,597 | 1,855 | 2,005 | 2,613 | |
Revenue Growth (YoY) | 1.82% | -1.50% | -13.92% | -7.47% | -23.26% | 29.30% |
Cost of Revenue | 1,129 | 1,090 | 1,095 | 1,294 | 1,476 | 1,913 |
Gross Profit | 491.58 | 483.31 | 502.03 | 561.3 | 528.47 | 699.91 |
Selling, General & Admin | 311.64 | 293.09 | 266.32 | 277.87 | 280.34 | 329.02 |
Research & Development | 97.95 | 93.3 | 80.1 | 80.18 | 88.66 | 119.21 |
Other Operating Expenses | -7.03 | -2.32 | 6.62 | 7.7 | 7.83 | 6.27 |
Operating Expenses | 402.56 | 384.08 | 355.83 | 364.86 | 382.33 | 460.41 |
Operating Income | 89.02 | 99.23 | 146.2 | 196.44 | 146.14 | 239.5 |
Interest Expense | - | - | -5.9 | -27.41 | -28.79 | -28.74 |
Interest & Investment Income | 93.16 | 64.57 | 53.88 | 64.11 | 44.37 | 104.76 |
Currency Exchange Gain (Loss) | - | - | 7.42 | 7.9 | 25.76 | -15.75 |
Other Non Operating Income (Expenses) | -14.76 | -16.78 | 3.06 | -7.2 | -27.66 | -58.25 |
EBT Excluding Unusual Items | 167.41 | 147.02 | 204.66 | 233.84 | 159.82 | 241.52 |
Gain (Loss) on Sale of Investments | 35.2 | 41.14 | -6.14 | -16.22 | 10.41 | 4.69 |
Gain (Loss) on Sale of Assets | 1.5 | 1.73 | 0.7 | -0.95 | 0.15 | 1.31 |
Asset Writedown | -5.11 | -5.45 | -1.21 | -1.29 | -0.01 | -1.7 |
Other Unusual Items | - | - | 11.98 | 14.81 | 9 | 15.13 |
Pretax Income | 199 | 184.42 | 209.99 | 230.19 | 179.37 | 260.96 |
Income Tax Expense | 23.81 | 34.43 | 18.19 | 26.86 | 14.65 | 32.93 |
Earnings From Continuing Operations | 175.18 | 150 | 191.81 | 203.33 | 164.72 | 228.03 |
Minority Interest in Earnings | 1.32 | 0.71 | 0.14 | -0.63 | -0.49 | 8.3 |
Net Income | 176.5 | 150.7 | 191.95 | 202.71 | 164.23 | 236.34 |
Net Income to Common | 176.5 | 150.7 | 191.95 | 202.71 | 164.23 | 236.34 |
Net Income Growth | 1.94% | -21.49% | -5.31% | 23.43% | -30.51% | 22.45% |
Shares Outstanding (Basic) | 187 | 182 | 173 | 173 | 174 | 176 |
Shares Outstanding (Diluted) | 187 | 182 | 198 | 173 | 174 | 182 |
Shares Change (YoY) | -4.42% | -8.24% | 14.21% | -0.18% | -4.53% | 2.16% |
EPS (Basic) | 0.94 | 0.83 | 1.11 | 1.17 | 0.95 | 1.35 |
EPS (Diluted) | 0.94 | 0.83 | 0.97 | 1.17 | 0.95 | 1.30 |
EPS Growth | 6.66% | -14.43% | -17.09% | 23.65% | -27.21% | 19.86% |
Free Cash Flow | 50.98 | 62.91 | 17.06 | 254.69 | 136.14 | 196.45 |
Free Cash Flow Per Share | 0.27 | 0.35 | 0.09 | 1.47 | 0.78 | 1.08 |
Dividend Per Share | - | - | 0.650 | 0.769 | 0.385 | 0.538 |
Dividend Growth | - | - | -15.50% | 100.00% | -28.58% | 40.02% |
Gross Margin | 30.34% | 30.73% | 31.44% | 30.26% | 26.36% | 26.79% |
Operating Margin | 5.50% | 6.31% | 9.16% | 10.59% | 7.29% | 9.17% |
Profit Margin | 10.89% | 9.58% | 12.02% | 10.93% | 8.19% | 9.05% |
Free Cash Flow Margin | 3.15% | 4.00% | 1.07% | 13.73% | 6.79% | 7.52% |
EBITDA | 144.15 | 154.41 | 201.57 | 256.39 | 204.07 | 292.8 |
EBITDA Margin | 8.90% | 9.82% | 12.62% | 13.82% | 10.18% | 11.21% |
D&A For EBITDA | 55.13 | 55.18 | 55.37 | 59.96 | 57.93 | 53.3 |
EBIT | 89.02 | 99.23 | 146.2 | 196.44 | 146.14 | 239.5 |
EBIT Margin | 5.50% | 6.31% | 9.16% | 10.59% | 7.29% | 9.17% |
Effective Tax Rate | 11.97% | 18.67% | 8.66% | 11.67% | 8.17% | 12.62% |
Revenue as Reported | - | - | 1,597 | 1,855 | 2,005 | 2,613 |
Advertising Expenses | - | - | 115.31 | 130.36 | 133.74 | 180.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.